Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Total Liabilities (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Total Liabilities for 3 consecutive years, with $91.4 million as the latest value for Q1 2026.

  • Quarterly Total Liabilities rose 7.0% to $91.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $91.4 million through Jan 2026, up 7.0% year-over-year, with the annual reading at $90.3 million for FY2025, 15.5% up from the prior year.
  • Total Liabilities for Q1 2026 was $91.4 million at Kestra Medical Technologies, up from $82.6 million in the prior quarter.
  • The five-year high for Total Liabilities was $236.5 million in Q4 2024, with the low at -$196.9 million in Q1 2024.
  • Average Total Liabilities over 3 years is $85.1 million, with a median of $85.4 million recorded in 2025.
  • Peak annual rise in Total Liabilities hit 143.36% in 2025, while the deepest fall reached 65.07% in 2025.
  • Over 3 years, Total Liabilities stood at $236.5 million in 2024, then plummeted by 65.07% to $82.6 million in 2025, then rose by 10.57% to $91.4 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $91.4 million, $82.6 million, and $82.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.